LOGIN
Volume:5
Issue:9
Number:39
ISSN#:2564-2537
Meta-Analysis
ACE Report #9096
Comparison of risedronate, alendronate, zoledronate, and ibandronate in those with low BMD
How to Cite
OrthoEvidence. Comparison of risedronate, alendronate, zoledronate, and ibandronate in those with low BMD. ACE Report. 2016;5(9):39. Available from: https://myorthoevidence.com/AceReport/Report/9096
Study Type:Meta analysis
OE Level Evidence:2
Journal Level of Evidence:N/A
Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysis
Bone. 2016 Aug;89:52-8Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
A total of 27 randomized controlled trials were included in this network meta-analysis investigating the comparative efficacies of bisphosphonates - including alendronate, ibandronate, risedronate, and zoledronic acid - versus placebo or control in patients with low bone mineral density. All studied drugs demonstrated significant effects on vertebral fracture incidence and bone mineral density of ...
To view the full report, start your 30-day free trial today
No credit card required
JOIN LOGIN Forgot Password?Not sure if you want to join OrthoEvidence?
Access this report without an Account.Success, an email containing a link to access this report has been sent to your inbox.
Explore some of our unlocked reports below!
.jpg)
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MOREFor Reprints and Permissions, click here
Please Login or Join to leave comments.